Alphamab Oncology (stock code: 9966.HK) announced that the preclinical data on two novel bispecific antibody-drug conjugates (ADCs) JSKN021 and JSKN022 were presented as posters at the 2025 American ...

The potential of computational chemistry to revolutionise cancer treatment in Nigeria represents a paradigm shift in medical ...

J INTS BIO, a company specializing in anticancer and orphan drugs, announced its research findings for the next-generation ...

The Incucyte ® Live-Cell Analysis System is a fully automated platform for phase contrast and two-color fluorescence imaging, ...

We are investigating the mechanisms by which cancer mutations deregulate the normal processes of cellular function and growth ...

Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer ... Allyl isothiocyanate induces replication-associated DNA ...

Artificial exosomes can be designed to encapsulate and deliver therapeutic payloads, including drugs, genes, and proteins.

Anti-EGFR therapies, such as cetuximab and panitumumab, are a cornerstone of treatment for many cancers, including colorectal cancer. However, they often cause an acneiform rash that frequently ...

But a decade later, the case still hasn't made it to trial. A battle over DNA evidence has stalled the case. After the Arizona Supreme Court decided it could be used at trial, suspect Ian Mitcham ...

The sale of the bankrupt DNA data bank 23andMe is facing delays as the company tries to find a lead bidder that can quickly clear regulatory hurdles and guarantee customer privacy rules will be ...